‘Paying Twice’: A Push for Affordable Prices for Taxpayer-Funded Drugs

By ROBERT PEAR
NYT Politics
The National Institutes of Health is helping to develop more cutting-edge drugs. But the agency says its mission doesn’t include evaluating prices, even when the drugs use breakthroughs it patented.
Published date: May 28, 2018 at 09:27PM
The New York Times
New York Times article